GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » Construction In Progress

Ajanta Pharma (BOM:532331) Construction In Progress : ₹2,565 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma Construction In Progress?

Ajanta Pharma's quarterly construction in progress declined from Sep. 2023 (₹2,048 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹2,565 Mil).

Ajanta Pharma's annual construction in progress increased from Mar. 2022 (₹1,529 Mil) to Mar. 2023 (₹2,095 Mil) and increased from Mar. 2023 (₹2,095 Mil) to Mar. 2024 (₹2,565 Mil).


Ajanta Pharma Construction In Progress Historical Data

The historical data trend for Ajanta Pharma's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma Construction In Progress Chart

Ajanta Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,318.60 1,081.90 1,528.60 2,094.70 2,564.50

Ajanta Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,094.70 - 2,047.50 - 2,564.50

Ajanta Pharma Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Ajanta Pharma (BOM:532331) Business Description

Traded in Other Exchanges
Address
Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067
Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma (BOM:532331) Headlines

No Headlines